Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSGeneric

SEROSTIM LQ

SOMATROPIN

Standard Dose
6MG/0.5ML (6MG/0.5ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview SEROSTIM LQ is listed in Drugs@FDA under application 020604 (BLA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient SOMATROPIN Form and strength INJECTABLE;SUBCUTANEOUS - 6MG/0.5ML (6MG/0.5ML) Sponsor EMD SERONO Submission history Latest submission status date: 2017-05-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview SEROSTIM LQ is listed in Drugs@FDA under application 020604 (BLA). Review priority: STANDARD Marketing status: Discontinued Active ingredient SOMATROPIN Form and strength INJECTABLE;SUBCUTANEOUS - 6MG/0.5ML (6MG/0.5ML) Sponsor EMD SERONO Submission history Latest submission status date: 2017-05-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.